Difficulty: Medium
Average Score: 62%
Practice
Indicate the hypnotic drug, which binds selectively to the BZÔéü receptor subtype, facilitating GABAergic inhibition:
Correct answer
B
Rationale
In this pharmacology/lifespan considerations exam question, the correct answer is B) Zolpidem. Zolpidem is a hypnotic drug that binds selectively to the BZÔéü receptor subtype, which in turn facilitates GABAergic inhibition. This mechanism of action results in sedative, anxiolytic, and muscle relaxant effects, making it effective for treating insomnia.
Now, let's discuss why the other options are incorrect:
A) Thiopental: Thiopental is a barbiturate that acts as a non-selective GABA receptor agonist, not specifically targeting the BZÔéü receptor subtype.
C) Flurazepam: Flurazepam is a benzodiazepine that binds to multiple subtypes of the GABA receptor, including BZÔéü, but it is not as selective for BZÔéü as zolpidem.
D) Phenobarbital: Phenobarbital is another barbiturate that, like thiopental, acts as a non-selective GABA receptor agonist and does not specifically target the BZÔéü receptor subtype.
Educationally, understanding the specific receptor subtypes targeted by different drugs is crucial in pharmacology. Knowing the mechanisms of action helps healthcare professionals make informed decisions when selecting appropriate medications for patients based on their conditions and desired outcomes. In the context of lifespan considerations, such knowledge becomes even more critical as drug responses can vary across different age groups, requiring tailored treatment approaches.
Now, let's discuss why the other options are incorrect:
A) Thiopental: Thiopental is a barbiturate that acts as a non-selective GABA receptor agonist, not specifically targeting the BZÔéü receptor subtype.
C) Flurazepam: Flurazepam is a benzodiazepine that binds to multiple subtypes of the GABA receptor, including BZÔéü, but it is not as selective for BZÔéü as zolpidem.
D) Phenobarbital: Phenobarbital is another barbiturate that, like thiopental, acts as a non-selective GABA receptor agonist and does not specifically target the BZÔéü receptor subtype.
Educationally, understanding the specific receptor subtypes targeted by different drugs is crucial in pharmacology. Knowing the mechanisms of action helps healthcare professionals make informed decisions when selecting appropriate medications for patients based on their conditions and desired outcomes. In the context of lifespan considerations, such knowledge becomes even more critical as drug responses can vary across different age groups, requiring tailored treatment approaches.